mab use for lymphoproliferative disorders", "sentences": [], "annotations": [], "relations": []}, {"offset": 37799, "infons": {"fpage": "26", "issue": "1", "lpage": "32", "name_0": "surname:Uppenkamp;given-names:M", "name_1": "surname:Engert;given-names:A", "name_2": "surname:Diehl;given-names:V", "name_3": "surname:Bunjes;given-names:D", "name_4": "surname:Huhn;given-names:D", "name_5": "surname:Brittinger;given-names:G", "pub-id_pmid": "11807632", "section_type": "REF", "source": "Ann Hematol", "type": "ref", "volume": "81", "year": "2002"}, "text": "Monoclonal antibody therapy with Campath-1H in patients with relapsed high- and low-grade non-Hodgkin's lymphomas: a multicenter phase I/II study", "sentences": [], "annotations": [], "relations": []}, {"offset": 37947, "infons": {"fpage": "546", "issue": "3", "lpage": "551", "name_0": "surname:Kothary;given-names:N", "name_1": "surname:Diak;given-names:IL", "name_2": "surname:Brinker;given-names:A", "name_3": "surname:Bezabeh;given-names:S", "name_4": "surname:Avigan;given-names:M", "name_5": "surname:Dal Pan;given-names:G", "pub-id_pmid": "21514689", "section_type": "REF", "source": "J Am Acad\nDermatol", "type": "ref", "volume": "65", "year": "2011"}, "text": "Progressive multifocal leukoencephalopathy associated with efalizumab use in psoriasis patients", "sentences": [], "annotations": [], "relations": []}, {"offset": 38043, "infons": {"fpage": "1535", "issue": "3", "lpage": "1542", "name_0": "surname:Duckett;given-names:CS", "name_1": "surname:Gedrich;given-names:RW", "name_2": "surname:Gilfillan;given-names:MC", "name_3": "surname:Thompson;given-names:CB", "pub-id_pmid": "9032281", "section_type": "REF", "source": "Mol Cell Biol", "type": "ref", "volume": "17", "year": "1997"}, "text": "Induction of nuclear factor kappaB by the CD30 receptor is mediated by TRAF1 and TRAF2", "sentences": [], "annotations": [], "relations": []}, {"offset": 38130, "infons": {"fpage": "669", "issue": "2", "lpage": "674", "name_0": "surname:Lee;given-names:SY", "name_1": "surname:Park;given-names:CG", "name_2": "surname:Choi;given-names:Y", "pub-id_pmid": "8627180", "section_type": "REF", "source": "J Exp Med", "type": "ref", "volume": "183", "year": "1996"}, "text": "T cell receptor-dependent cell death of T cell hybridomas mediated by the CD30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors", "sentences": [], "annotations": [], "relations": []}, {"offset": 38298, "infons": {"fpage": "2045", "issue": "8", "lpage": "2056", "name_0": "surname:Gruss;given-names:HJ", "name_1": "surname:Boiani;given-names:N", "name_2": "surname:Williams;given-names:DE", "name_3": "surname:Armitage;given-names:RJ", "name_4": "surname:Smith;given-names:CA", "name_5": "surname:Goodwin;given-names:RG", "pub-id_pmid": "8161776", "section_type": "REF", "source": "Blood", "type": "ref", "volume": "83", "year": "1994"}, "text": "Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines", "sentences": [], "annotations": [], "relations": []}, {"offset": 38386, "infons": {"fpage": "3197", "issue": "22", "lpage": "3200", "name_0": "surname:Ansell;given-names:SM", "pub-id_pmid": "25293772", "section_type": "REF", "source": "Blood", "type": "ref", "volume": "124", "year": "2014"}, "text": "Brentuximab vedotin", "sentences": [], "annotations": [], "relations": []}, {"offset": 38406, "infons": {"fpage": "816", "issue": "8", "lpage": "824", "name_0": "surname:Carson;given-names:KR", "name_1": "surname:Focosi;given-names:D", "name_2": "surname:Major;given-names:EO", "pub-id_pmid": "19647202", "section_type": "REF", "source": "Lancet Oncol", "type": "ref", "volume": "10", "year": "2009"}, "text": "Monoclonal antibody-associated progressive multifocal leukoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a review from the Research on Adverse Drug Events and Reports (RADAR) Project", "sentences": [], "annotations": [], "relations": []}, {"offset": 38623, "infons": {"fpage": "2464", "issue": "16", "lpage": "2471", "name_0": "surname:Carson;given-names:KR", "name_1": "surname:Newsome;given-names:SD", "name_2": "surname:Kim;given-names:EJ", "pub-id_pmid": "24771533", "section_type": "REF", "source": "Cancer", "type": "ref", "volume": "120", "year": "2014"}, "text": "Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: a report of 5 cases from the Southern Network on Adverse Reactions (SONAR) project", "sentences": [], "annotations": [], "relations": []}, {"offset": 38794, "infons": {"fpage": "343", "issue": "3", "lpage": "351", "name_0": "surname:Owen;given-names:C", "name_1": "surname:Stewart;given-names:DA", "pub-id_pmid": "22283718", "section_type": "REF", "source": "Expert Opin Biol Ther", "type": "ref", "volume": "12", "year": "2012"}, "text": "Obinutuzumab for the treatment of lym